UAE opens regional COVID-19 vaccination site for Chinese nationals | Inquirer News

UAE opens regional COVID-19 vaccination site for Chinese nationals

/ 01:41 PM May 25, 2021

DUBAI — The United Arab Emirates will offer China’s Sinopharm vaccine to Chinese nationals visiting the regional tourism and business hub, the first non-residents to be eligible for the country’s vaccination campaign against COVID-19.

Chinese nationals over the age of 16 holding a short-term visa can receive two doses of Sinopharm in Dubai, the state news agency WAM said earlier this week, under an agreement between the UAE and China to launch a regional vaccination site.

The UAE led Phase III clinical trials of the vaccine produced by China’s state-owned drugmaker Sinopharm and has started manufacturing it under a joint venture between Sinopharm and Abu Dhabi-based technology company Group 42.

ADVERTISEMENT

The Gulf Arab state, a country of some 9 million people, has vaccinated about 73% of its eligible population, authorities have said.

FEATURED STORIES

It recorded 1,512 new COVID-19 infections on Monday to take its total to 557,610 cases and 1,654 deaths.

The UAE, which is offering four vaccines, said this month it would start offering a booster shot of Sinopharm.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: China, COVID-19, Sinopharm, UAE

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.